Bill Sponsor
House Bill 568
118th Congress(2023-2024)
SAFE Act
Introduced
Introduced
Introduced in House on Jan 26, 2023
Overview
Text
Introduced
Jan 26, 2023
Latest Action
Feb 3, 2023
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
568
Congress
118
Policy Area
Crime and Law Enforcement
Crime and Law Enforcement
Primary focus of measure is criminal offenses, investigation and prosecution, procedure and sentencing; corrections and imprisonment; juvenile crime; law enforcement administration. Measures concerning terrorism may fall under Emergency Management or International Affairs policy areas.
Sponsorship by Party
Democrat
New Hampshire
Democrat
California
Democrat
California
Democrat
California
Democrat
Colorado
Democrat
Michigan
Democrat
Minnesota
Democrat
North Carolina
Democrat
Rhode Island
Republican
Washington
Democrat
Washington
House Votes (0)
Senate Votes (0)
No House votes have been held for this bill.
Summary

Save Americans from the Fentanyl Emergency Act or the SAFE Act

This bill permanently places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. The temporary scheduling order issued by the Drug Enforcement Administration to place fentanyl-related substances into schedule I of the Controlled Substances Act expires on December 31, 2024.

It limits the application of mandatory minimum penalties for certain offenses involving fentanyl-related substances, establishes a process to deschedule or remove certain fentanyl-related substances that have a low potential for abuse, and allows a federal court to vacate or reduce the sentence for convictions of offenses involving a fentanyl-related substance that is descheduled or moved to a schedule other than schedule I or II.

The bill establishes a new, alternative registration process for schedule I research. It also makes other changes to registration requirements for conducting research with controlled substances, including

  • permitting a single registration for related research sites in certain circumstances,
  • waiving the requirement for a new inspection in certain situations, and
  • allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration.

Finally, the bill requires the Government Accountability Office to analyze the implementation and impact of permanently placing fentanyl-related substances into schedule I of the Controlled Substances Act.

Text (1)
January 26, 2023
Actions (4)
02/03/2023
Referred to the Subcommittee on Health.
02/01/2023
Sponsor introductory remarks on measure. (CR H588)
01/26/2023
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
01/26/2023
Introduced in House
Public Record
Record Updated
Mar 18, 2024 8:28:11 PM